Amneal Pharmaceuticals, Inc

(NYSE:AMRX)

Latest On Amneal Pharmaceuticals, Inc (AMRX):

Date/Time Type Description Signal Details
2023-05-05 23:59 ESTNewsAmneal Pharmaceuticals, Inc. 2023 Q1 - Results - Earnings Call PresentationN/A
2023-05-05 23:59 ESTNewsAmneal Pharmaceuticals, Inc. (AMRX) Q1 2023 Earnings Call TranscriptN/A
2023-05-05 11:00 ESTNewsAmneal Pharmaceuticals Non-GAAP EPS of $0.12 beats by $0.02, revenue of $558M beats by $15.82MN/A
2023-05-04 22:14 ESTNewsAmneal Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-04-17 18:46 ESTNewsAmneal pops 3% after early look at Q1 results, re-affirms FY23 guidanceN/A
2023-03-10 04:46 ESTNewsGene therapy developer AskBio appoints ex Amneal commercial chief as CEON/A
2023-03-02 13:04 ESTNewsAmneal Pharmaceuticals Non-GAAP EPS of $0.23 beats by $0.02, revenue of $610M beats by $30.07MN/A
2023-03-02 13:04 ESTNewsAmneal stock rises ~15% on FDA review of Narcan generic, Q4 beatN/A
2023-03-02 13:03 ESTNewsAmneal Pharmaceuticals, Inc. (AMRX) Q4 2022 Earnings Call TranscriptN/A
2023-03-01 22:47 ESTNewsAmneal Pharmaceuticals Q4 2022 Earnings PreviewN/A
2023-01-25 13:44 ESTNewsIntercept Pharma gains after patent settlement with AmnealN/A
2023-01-24 00:26 ESTNewsAmneal Pharmaceuticals: Risk Still PersistsN/A
2023-01-15 19:42 ESTNewsDrugmakers welcome new year with 450 drug price hikes so farN/A
2023-01-11 19:58 ESTNewsAmneal Pharmaceuticals (AMRX) presents at 41st Annual J.P. Morgan Healthcare Conference - SlideshowN/A
2023-01-10 19:47 ESTNewsAmneal Pharma reaffirms 2022 guidanceN/A
2023-01-04 16:19 ESTNewsAmneal joins hands with Orion to commercialize generic products in Europe and more countriesN/A
2022-12-15 05:51 ESTNewsAmneal Pharmaceuticals large shareholder TPG cuts stakeN/A
2022-11-12 00:59 ESTNewsFDA accepts Amneal Pharmaceuticals NDA for Parkinson's drug IPX203N/A
2022-11-04 15:45 ESTNewsAmneal Pharmaceuticals Non-GAAP EPS of $0.14 misses by $0.04, revenue of $545.56M misses by $16.61MN/A
2022-11-04 15:45 ESTNewsAmneal Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call PresentationN/A
2022-11-04 15:44 ESTNewsAmneal Pharmaceuticals, Inc. (AMRX) Q3 2022 Earnings Call TranscriptN/A
2022-11-03 23:09 ESTNewsAmneal Pharmaceuticals Q3 2022 Earnings PreviewN/A
2022-11-02 13:25 ESTNewsAMD, JD and BILI are among pre market gainersN/A
2022-11-02 13:25 ESTNewsAmneal Pharma gets FDA nod for leuprolide acetate injection to treat prostate cancerN/A
2022-10-28 12:24 ESTNewsAmneal Pharmaceuticals: A Small 'Thumbs Up'N/A
2022-09-01 01:51 ESTNewsAmneal Pharma submits NDA for novel formulation of Parkinson's disease treatmentN/A
2022-08-06 06:05 ESTNewsAmneal Pharmaceuticals, Inc. (AMRX) Management Team on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-05 14:38 ESTNewsAmneal Pharmaceuticals Non-GAAP EPS of $0.19 in-line, revenue of $559M beats by $24.56M, revises FY earning guidanceN/A
2022-08-05 14:37 ESTNewsAmneal shares lower after generic drugmaker cuts FY 2022 profit outlookN/A
2022-08-04 23:18 ESTNewsAmneal Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-06-01 11:05 ESTNewsAmneal launches Lyvispah for muscle tightness due to spinal cord & neurological disordersN/A
2022-05-27 16:22 ESTNewsAmneal, Kashiv's biosimilar therapy to Amgen's Neulasta gets FDA approvalN/A
2022-05-04 22:47 ESTNewsAmneal Pharmaceuticals Non-GAAP EPS of $0.12 misses by $0.01, revenue of $497.63M misses by $4.66MN/A
2022-05-04 22:44 ESTNewsAmneal falls 12% on disappointing Q1 resultN/A
2022-05-04 22:43 ESTNewsAmneal Pharmaceuticals, Inc. (AMRX) Management Team on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-04 22:43 ESTNewsAmneal Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-04 03:16 ESTNewsAmneal Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-04-14 04:45 ESTNewsAmneal Pharmaceuticals gets second U.S. biosimilar approval with FDA nod for AlymsysN/A
2022-03-31 06:49 ESTNewsAmneal Pharmaceuticals: Generics And Biosimilars Play Has Strong Upside Potential Under New / Old ManagementN/A
2022-03-02 13:22 ESTNewsAmneal Pharmaceuticals Non-GAAP EPS of $0.18 misses by $0.02, revenue of $537M beats by $3.59MN/A
2022-03-02 13:21 ESTNewsAmneal Pharmaceuticals, Inc. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-03-02 13:21 ESTNewsAmneal stock falls 8% following Q4 results; FY22 EPS outlook seen below estimatesN/A
2022-03-02 13:21 ESTNewsAmneal Pharmaceuticals (AMRX) CEO, Chirag Patel on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-01 21:00 ESTNewsAmneal Pharmaceuticals Q4 2021 Earnings PreviewN/A
2022-02-17 10:31 ESTNewsAmneal gets FDA nod for 4 generic injectables productsN/A
2022-01-05 17:08 ESTNewsAmneal acquires Saol Therapeutics’ Baclofen franchise for $83.5MN/A
2021-12-22 12:19 ESTNewsRevisiting Amneal Pharmaceuticals After Its CEO Buys SharesN/A
2021-11-20 04:05 ESTNewsAmneal receives ANDA approval for difluprednate ophthalmic emulsionN/A
2021-11-04 03:51 ESTNewsAmneal Pharmaceuticals, Inc. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-04 03:51 ESTNewsAmneal Pharmaceuticals, Inc. (AMRX) CEO Chintu Patel on Q3 2021 Results - Earnings Call TranscriptN/A

About Amneal Pharmaceuticals, Inc (AMRX):

Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates in three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in the development, promotion, distribution, and sale of branded pharmaceutical products primarily for central nervous system disorders, endocrinology, parasitic infections, and other therapeutic areas. It also offers licensed, owned, niche, and mature branded products, as well as Rytary for the treatment of Parkinson's disease; Zomig for the treatment of migraine headaches; Emverm a chewable tablets for the treatment of pinworm, whipworm, common roundworm, common hookworm, and American hookworm in single or mixed infections; and Unithroid for the treatment of hypothyroidism. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs. It is also involved in the wholesale distribution of bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names, as well as medical and surgical products; and packaging and wholesale distribution of pharmaceuticals and vitamins to its retail and institutional customers. The company sells its products through wholesalers, distributors, hospitals, chain pharmacies, and individual pharmacies. It operates in the United States, India, Ireland, and internationally. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is based in Bridgewater, New Jersey.

AMRX Quotes by TradingView

See Advanced Chart

General

  • Name Amneal Pharmaceuticals, Inc
  • Symbol AMRX
  • Type Common Stock
  • Exchange NYSE
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 6,000
  • Fiscal Year EndDecember
  • IPO Date2009-01-15
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.amneal.com
View More

Valuation

  • Trailing PE 11.33
  • Forward PE 8.36
  • Price/Sales (Trailing 12 Mt.) 0.45
  • Price/Book (Most Recent Quarter) 2.93
  • Enterprise Value Revenue 1.75
  • Enterprise Value EBITDA 10.1
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $0.78
  • Next Year EPS Estimate $0.87
  • Next Quarter EPS Estimate $0.16
  • Profit Margin 5%
  • Operating Margin 7%
  • Return on Assets 2%
  • Return on Equity 20%
  • Revenue 1.99 billion
  • Earnings Per Share $0.61
  • Revenue Per Share $13.51
  • Gross Profit 652.32 million
  • Quarterly Earnings Growth 28.4%
View More

Highlights

  • Market Capitalization 1.02 billion
  • EBITDA 381.05 million
  • PE Ratio -15.35
  • Analyst Target Price $6.1
  • Book Value Per Share $2.05
View More

Share Statistics

  • Shares Outstanding 147.7 million
  • Shares Float 94.49 million
  • % Held by Insiders 1043%
  • % Held by Institutions 69.86%
  • Shares Short 5.45 million
  • Shares Short Prior Month 4.99 million
  • Short Ratio 3.45
  • Short % of Float 7%
  • Short % of Shares Outstanding 4%
View More

Technicals

  • Beta 1.29
  • 52 Week High $7.32
  • 52 Week Low $2.71
  • 50 Day Moving Average 5.49
  • 200 Day Moving Average 4.67
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Amneal Pharmaceuticals, Inc (AMRX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Amneal Pharmaceuticals, Inc (AMRX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-26$N/A$0.14$0.135.42%
2020-09-302020-11-06$N/A$0.16$0.1231.58%
2020-06-302020-08-06$N/A$0.13$0.1034.85%
2020-03-312020-05-11$498.53 million$0.20$0.09123.21%
2019-12-312020-02-26$397.33 million$0.08$0.0556.56%
2019-09-302019-11-06$378.28 million$0.04$0.13-68.6%
2019-06-302019-08-05$404.64 million$0.09$0.12-27.18%
2019-03-312019-05-09$446.12 million$0.14$0.18-20.95%
2018-12-312019-02-28$497.53 million$0.33$0.2721.01%
2018-09-302018-11-07$476.49 million$0.28$0.272.23%
2018-06-302018-08-09$413.79 million$0.24$0.227.33%
2018-03-312018-05-11$275.19 million$0.14$0.17-17.65%
2017-12-312018-03-01$1.03 billion$0.11$0.110%
2017-09-302017-11-09$-107085000$0.23$0.2015%
2017-06-302017-08-09$478.56 million$0.18$0.1428.57%
2017-03-312017-05-10$-371471000$0.11$0.13-15.38%
2016-12-312017-03-01$298.58 million$0.16$0.160%
2016-09-302016-11-09$0.37$0.39-5.13%
2016-06-302016-08-09$0.21$0.32-34.38%
2016-03-312016-05-10$0.43$0.3910.26%
2015-12-312016-02-22$0.62$0.4440.91%
2015-09-302015-11-09$0.40$0.392.56%
2015-06-302015-08-10$0.34$0.35-2.86%
2015-03-312015-05-11$0.09$0.18-50%
2014-12-312015-02-24$0.16$0.1233.33%
2014-09-302014-11-04$0.33$0.316.45%
2014-06-302014-08-06$0.60$0.3666.67%
2014-03-312014-05-01$0.24$0.05380%
2013-12-312014-02-20-$0.02$0.03-166.67%
2013-09-302013-11-04$0.25-$0.07457.14%
2013-06-302013-08-08$0.23$0.04475%
2013-03-312013-05-01$0.37$0.2085%
2012-12-312013-02-25$0.30$0.1957.89%
2012-09-302012-10-30$0.48$0.50-4%
2012-06-302012-07-31$0.60$0.4533.33%
2012-03-312012-05-01$0.55$0.4912.24%
2011-12-312012-02-28$0.36$0.2263.64%
2011-09-302011-11-01$0.30$0.2330.43%
2011-06-302011-08-02$0.22$0.1915.79%
2011-03-312011-05-03$0.24$0.1560%
2010-12-312011-02-24$0.23$0.224.55%
2010-09-302010-11-02$0.24$0.26-7.69%
2010-06-302010-08-03$0.48$0.51-5.88%
2010-03-312010-05-04$2.06$0.51303.92%
2009-12-312010-02-25$0.69$0.14392.86%
2009-09-302009-11-03$0.11$0.05120%
2009-06-302009-08-04$0.05$0.0366.67%
2004-09-302004-11-09$0.01$0.05-80%
2004-06-302004-08-04$0.01$0.03-66.67%
2004-03-312004-05-05$0.14-$0.03566.67%
2003-12-312004-02-17-$0.05-$0.050%
2003-09-302003-11-05-$0.07-$0.02-250%
2003-06-302003-07-28-$0.05-$0.0616.67%
2003-03-312003-04-30-$0.07-$0.0812.5%
2002-12-312003-02-12-$0.07-$0.1136.36%
2002-09-302002-10-28-$0.11-$0.1315.38%
2002-06-302002-07-25-$0.13-$0.12-8.33%
2002-03-312002-04-30-$0.12-$0.137.69%
2001-12-312002-02-07-$0.15-$0.14-7.14%
2001-09-302001-10-30-$0.15-$0.14-7.14%
2001-06-302001-07-31-$0.15-$0.1816.67%
2001-03-312001-05-02-$0.16-$0.2123.81%
2000-12-312001-02-08-$0.20-$0.2313.04%
2000-09-302000-10-31-$0.18-$0.2114.29%
2000-06-302000-07-31-$0.21-$0.18-16.67%

Amneal Pharmaceuticals, Inc (AMRX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Amneal Pharmaceuticals, Inc (AMRX) Chart:

Amneal Pharmaceuticals, Inc (AMRX) News:

Below you will find a list of latest news for Amneal Pharmaceuticals, Inc (AMRX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Amneal Pharmaceuticals, Inc (AMRX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-03-202.59.5CALL0 0417.84TRUE00
2026-03-2056.4CALL0 10334.28TRUE00
2026-03-207.56.5CALL0 27226.8TRUE00
2026-03-20103.55CALL40 18690TRUE3.550
2026-03-2012.51.47CALL3 440346.56TRUE-0.73-0.33
2026-03-20150.2CALL331 48445.68FALSE-0.55-0.73
2026-03-2017.50.4CALL5 261110.95FALSE0.170.74
2026-03-20200CALL0 0300.02FALSE00
2026-03-2022.50.01CALL0 7333.99FALSE00
2026-03-20251.05CALL0 10362.49FALSE00
2026-03-202.50PUT0 00FALSE00
2026-03-2050PUT0 0765.89FALSE00
2026-03-207.50PUT0 0510.04FALSE00
2026-03-20100.15PUT0 16213.87FALSE00
2026-03-2012.50.35PUT0 20784.31FALSE00
2026-03-20151.7PUT0 623.86TRUE00
2026-03-2017.50PUT0 00TRUE00
2026-03-20200PUT0 00TRUE00
2026-03-2022.50PUT0 0133.12TRUE00
2026-03-20250PUT0 0154.31TRUE00
2026-04-172.50CALL0 0265.63TRUE00
2026-04-1750CALL0 0175.03TRUE00
2026-04-177.50CALL0 0136.62TRUE00
2026-04-17100CALL0 099.67TRUE00
2026-04-1712.50CALL0 080.25TRUE00
2026-04-17150CALL0 098.46FALSE00
2026-04-1717.50CALL0 0170.9FALSE00
2026-04-17200CALL0 0193.1FALSE00
2026-04-1722.50CALL0 0215.07FALSE00
2026-04-17250CALL0 0233.49FALSE00
2026-04-17300CALL0 0263.24FALSE00
2026-04-172.50PUT0 01026.57FALSE00
2026-04-1750PUT0 0495.53FALSE00
2026-04-177.50PUT0 0344.13FALSE00
2026-04-17100.4PUT0 401251.7FALSE00
2026-04-1712.50.95PUT0 1187.43FALSE00
2026-04-17150PUT0 065.66TRUE00
2026-04-1717.50PUT0 063.98TRUE00
2026-04-17200PUT0 073.5TRUE00
2026-04-1722.50PUT0 090.21TRUE00
2026-04-17250PUT0 0104.57TRUE00
2026-04-17300PUT0 0128.47TRUE00
2026-06-182.50CALL0 0169.1TRUE00
2026-06-1857.55CALL0 1129.19TRUE00
2026-06-187.58.5CALL0 2113.13TRUE00
2026-06-18104.1CALL40 7050.54TRUE-1.3-0.24
2026-06-1812.53CALL5 2377.44TRUE30
2026-06-18151.76CALL0 4861.49FALSE00
2026-06-1817.50.5CALL0 8121.93FALSE00
2026-06-18200.68CALL0 2120.03FALSE00
2026-06-1822.50CALL0 0144.71FALSE00
2026-06-18250CALL0 0155.25FALSE00
2026-06-182.50PUT0 0683.41FALSE00
2026-06-1850PUT0 0343.75FALSE00
2026-06-187.50.3PUT0 7244.29FALSE00
2026-06-18100.4PUT1 1165.59FALSE-0.35-0.47
2026-06-1812.50.9PUT0 1209112.17FALSE00
2026-06-18152.45PUT0 255.9TRUE00
2026-06-1817.50PUT0 050.74TRUE00
2026-06-18200PUT0 058.87TRUE00
2026-06-1822.50PUT0 068.02TRUE00
2026-06-18250PUT0 074.52TRUE00
2026-09-182.511CALL0 1116.59TRUE00
2026-09-18510CALL0 1590.29TRUE00
2026-09-187.50CALL0 080.52TRUE00
2026-09-18106CALL0 260.65TRUE00
2026-09-1812.55.05CALL0 861.08TRUE00
2026-09-18153.2CALL0 3963.79FALSE00
2026-09-1817.51.8CALL0 1275.59FALSE00
2026-09-18202.9CALL0 297.63FALSE00
2026-09-1822.50CALL0 0104.76FALSE00
2026-09-18250CALL0 0112.56FALSE00
2026-09-182.50PUT0 0509.86FALSE00
2026-09-1850.05PUT0 12150.09FALSE00
2026-09-187.50.2PUT0 6124.29FALSE00
2026-09-18100PUT0 0133.69FALSE00
2026-09-1812.51.7PUT6 1062.2FALSE1.70
2026-09-18150PUT0 051.44TRUE00
2026-09-1817.50PUT0 045.06TRUE00
2026-09-18200PUT0 044.45TRUE00
2026-09-1822.58.5PUT0 051.36TRUE00
2026-09-182511.55PUT0 059.4TRUE00

Latest AMRX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$3.03
Jun 13, 2022 7:59 PM EST100$3.03
Jun 13, 2022 7:59 PM EST415$3.03
Jun 13, 2022 7:59 PM EST200$3.03
Jun 13, 2022 7:59 PM EST100$3.03

Amneal Pharmaceuticals, Inc (AMRX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000120919120030339/0001209191-20-030339-index.htm
2018-11-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1723128/000008025518002959/0000080255-18-002959-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1723128/000008025519002754/0000080255-19-002754-index.htm
2019-09-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1723128/000008025519002934/0000080255-19-002934-index.htm
2019-12-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1723128/000008025519003018/0000080255-19-003018-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1723128/000021545719006845/0000215457-19-006845-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1723128/000031506619000863/0000315066-19-000863-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1723128/000031506620000784/0000315066-20-000784-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1723128/000083423720004817/0000834237-20-004817-index.htm
2019-08-26SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1723128/000089843219001108/0000898432-19-001108-index.htm
2019-08-26SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1723128/000089843219001109/0000898432-19-001109-index.htm
2019-09-11SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1723128/000089843219001162/0000898432-19-001162-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320006625/0000899243-20-006625-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320006627/0000899243-20-006627-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320006629/0000899243-20-006629-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320006633/0000899243-20-006633-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320006635/0000899243-20-006635-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320006636/0000899243-20-006636-index.htm
2020-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320006637/0000899243-20-006637-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320006807/0000899243-20-006807-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320006808/0000899243-20-006808-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320006809/0000899243-20-006809-index.htm
2020-03-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320007819/0000899243-20-007819-index.htm
2020-03-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320007820/0000899243-20-007820-index.htm
2020-03-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320007821/0000899243-20-007821-index.htm
2020-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320007988/0000899243-20-007988-index.htm
2020-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320007990/0000899243-20-007990-index.htm
2020-03-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320008424/0000899243-20-008424-index.htm
2020-03-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320008429/0000899243-20-008429-index.htm
2020-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320009026/0000899243-20-009026-index.htm
2020-05-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320012068/0000899243-20-012068-index.htm
2020-05-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320012183/0000899243-20-012183-index.htm
2020-05-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320012185/0000899243-20-012185-index.htm
2020-05-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320012186/0000899243-20-012186-index.htm
2020-05-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320012187/0000899243-20-012187-index.htm
2020-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320012257/0000899243-20-012257-index.htm
2020-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320012259/0000899243-20-012259-index.htm
2020-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320012261/0000899243-20-012261-index.htm
2020-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320012265/0000899243-20-012265-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320012444/0000899243-20-012444-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320012451/0000899243-20-012451-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320012452/0000899243-20-012452-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320012453/0000899243-20-012453-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000089924320012466/0000899243-20-012466-index.htm
2018-11-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1723128/000090221918000529/0000902219-18-000529-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1723128/000090221919000126/0000902219-19-000126-index.htm
2020-01-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1723128/000090221920000328/0000902219-20-000328-index.htm
2019-08-07SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1723128/000091412119002136/0000914121-19-002136-index.htm
2019-08-07SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1723128/000091412119002138/0000914121-19-002138-index.htm
2019-01-31SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1723128/000093247119002240/0000932471-19-002240-index.htm
2019-02-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1723128/000093247119004732/0000932471-19-004732-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1723128/000110465920017627/0001104659-20-017627-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1723128/000110465920018499/0001104659-20-018499-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1723128/000110465920020703/0001104659-20-020703-index.htm
2019-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000114420419038060/0001144204-19-038060-index.htm
2019-08-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000114420419038365/0001144204-19-038365-index.htm
2018-11-13424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1723128/000119312518325599/0001193125-18-325599-index.htm
2019-03-018-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000119312519059421/0001193125-19-059421-index.htm
2019-03-01POSASRPost-effective Amendment to an automatic shelf registration statementhttps://www.sec.gov/Archives/edgar/data/1723128/000119312519059683/0001193125-19-059683-index.htm
2019-03-01S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1723128/000119312519061022/0001193125-19-061022-index.htm
2019-10-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000119312519266540/0001193125-19-266540-index.htm
2019-10-11PRE 14COther preliminary information statementshttps://www.sec.gov/Archives/edgar/data/1723128/000119312519266797/0001193125-19-266797-index.htm
2019-10-21DEF 14COther definitive information statementshttps://www.sec.gov/Archives/edgar/data/1723128/000119312519270854/0001193125-19-270854-index.htm
2019-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000119312519310283/0001193125-19-310283-index.htm
2019-12-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000119312519315267/0001193125-19-315267-index.htm
2020-01-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000119312520007787/0001193125-20-007787-index.htm
2020-02-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000119312520023178/0001193125-20-023178-index.htm
2020-02-208-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000119312520043609/0001193125-20-043609-index.htm
2020-02-208-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000119312520043613/0001193125-20-043613-index.htm
2020-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000119312520050188/0001193125-20-050188-index.htm
2020-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000119312520071730/0001193125-20-071730-index.htm
2020-04-15DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1723128/000119312520108170/0001193125-20-108170-index.htm
2020-04-178-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000119312520110622/0001193125-20-110622-index.htm
2020-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000119312520136972/0001193125-20-136972-index.htm
2020-08-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000119312520209316/0001193125-20-209316-index.htm
2020-08-17S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1723128/000119312520222437/0001193125-20-222437-index.htm
2020-01-093Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000120919120002856/0001209191-20-002856-index.htm
2020-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000120919120004719/0001209191-20-004719-index.htm
2020-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000120919120009662/0001209191-20-009662-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000120919120029727/0001209191-20-029727-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000120919120030339/0001209191-20-030339-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000120919120044578/0001209191-20-044578-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000120919120044579/0001209191-20-044579-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000120919120044581/0001209191-20-044581-index.htm
2019-03-22DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1723128/000130817919000058/0001308179-19-000058-index.htm
2019-03-22DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1723128/000130817919000059/0001308179-19-000059-index.htm
2020-03-23DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1723128/000130817920000070/0001308179-20-000070-index.htm
2020-03-23DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1723128/000130817920000071/0001308179-20-000071-index.htm
2019-07-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000138713119005208/0001387131-19-005208-index.htm
2019-07-19SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1723128/000138713119005210/0001387131-19-005210-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000156459019040651/0001564590-19-040651-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1723128/000156459019041240/0001564590-19-041240-index.htm
2020-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000156459020006564/0001564590-20-006564-index.htm
2020-03-0210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1723128/000156459020008179/0001564590-20-008179-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000156459020023833/0001564590-20-023833-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1723128/000156459020024256/0001564590-20-024256-index.htm
2019-11-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000162828019013997/0001628280-19-013997-index.htm
2018-12-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000172312818000039/0001723128-18-000039-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000005/0001723128-19-000005-index.htm
2019-01-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000007/0001723128-19-000007-index.htm
2019-01-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000009/0001723128-19-000009-index.htm
2019-01-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000011/0001723128-19-000011-index.htm
2019-01-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000013/0001723128-19-000013-index.htm
2019-01-233Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000015/0001723128-19-000015-index.htm
2019-01-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000017/0001723128-19-000017-index.htm
2019-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000019/0001723128-19-000019-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000023/0001723128-19-000023-index.htm
2019-03-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1723128/000172312819000028/0001723128-19-000028-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000033/0001723128-19-000033-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000034/0001723128-19-000034-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000035/0001723128-19-000035-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000036/0001723128-19-000036-index.htm
2019-03-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000038/0001723128-19-000038-index.htm
2019-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000040/0001723128-19-000040-index.htm
2019-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000042/0001723128-19-000042-index.htm
2019-05-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000049/0001723128-19-000049-index.htm
2019-05-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000050/0001723128-19-000050-index.htm
2019-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000064/0001723128-19-000064-index.htm
2019-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000065/0001723128-19-000065-index.htm
2019-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000066/0001723128-19-000066-index.htm
2019-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000067/0001723128-19-000067-index.htm
2019-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000068/0001723128-19-000068-index.htm
2019-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000069/0001723128-19-000069-index.htm
2019-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000070/0001723128-19-000070-index.htm
2019-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000071/0001723128-19-000071-index.htm
2019-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000072/0001723128-19-000072-index.htm
2019-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000073/0001723128-19-000073-index.htm
2019-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000074/0001723128-19-000074-index.htm
2019-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000076/0001723128-19-000076-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1723128/000172312819000079/0001723128-19-000079-index.htm
2019-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000081/0001723128-19-000081-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000087/0001723128-19-000087-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000088/0001723128-19-000088-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000089/0001723128-19-000089-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000090/0001723128-19-000090-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000091/0001723128-19-000091-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000094/0001723128-19-000094-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000095/0001723128-19-000095-index.htm
2019-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000097/0001723128-19-000097-index.htm
2019-07-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000100/0001723128-19-000100-index.htm
2019-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000105/0001723128-19-000105-index.htm
2019-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000107/0001723128-19-000107-index.htm
2019-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1723128/000172312819000111/0001723128-19-000111-index.htm
2019-08-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000112/0001723128-19-000112-index.htm
2019-08-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000114/0001723128-19-000114-index.htm
2019-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000116/0001723128-19-000116-index.htm
2019-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000118/0001723128-19-000118-index.htm
2019-08-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000120/0001723128-19-000120-index.htm
2019-11-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000127/0001723128-19-000127-index.htm
2019-11-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000128/0001723128-19-000128-index.htm
2019-11-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000129/0001723128-19-000129-index.htm
2019-11-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000130/0001723128-19-000130-index.htm
2019-11-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000131/0001723128-19-000131-index.htm
2019-12-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000138/0001723128-19-000138-index.htm
2019-12-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000139/0001723128-19-000139-index.htm
2019-12-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000140/0001723128-19-000140-index.htm
2019-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000144/0001723128-19-000144-index.htm
2019-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000145/0001723128-19-000145-index.htm
2019-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312819000146/0001723128-19-000146-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1723128/000172312820000002/0001723128-20-000002-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000172312820000010/0001723128-20-000010-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1723128/000172312820000013/0001723128-20-000013-index.htm
2020-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1723128/000172312820000023/0001723128-20-000023-index.htm
2020-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1723128/000172312820000026/0001723128-20-000026-index.htm

Amneal Pharmaceuticals, Inc (AMRX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Amneal Pharmaceuticals, Inc (AMRX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1043%
Institutional Ownership: 6986%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-05-19John KielyDirectorBuy10,000.004.4044,000.0010,000.00https://www.sec.gov/Archives/edgar/data/1723128/000120919120030339/0001209191-20-030339-index.htm
2019-05-07Robert A StewartPresident and CEOBuy83,277.00100,277.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000088/0001723128-19-000088-index.htm
2020-03-01ANDREW S BOYERExec VP, Comm OptnsBuy12,345.00108,313.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320006808/0000899243-20-006808-index.htm
2020-05-07ANDREW S BOYERExec VP, Comm OptnsBuy16,656.00118,286.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320012466/0000899243-20-012466-index.htm
2020-05-07Emily Peterson AlvaDirectorBuy6,459.0012,566.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320012265/0000899243-20-012265-index.htm
2020-03-17PAUL M MEISTERDirectorBuy149,439.002.79416,934.81149,439.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320009026/0000899243-20-009026-index.htm
2020-03-03Gautam PatelDirectorBuy117,889.003.94464,482.66156,107.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320007820/0000899243-20-007820-index.htm
2020-05-07Gautam PatelDirectorBuy6,459.00162,566.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320012259/0000899243-20-012259-index.htm
2019-08-05International Ltd Fosun10% Share HolderBuy1,642,300.003.044,992,592.001,642,300.00https://www.sec.gov/Archives/edgar/data/1723128/000114420419038060/0001144204-19-038060-index.htm
2019-03-12PAUL BISAROExecutive ChairmanBuy17,000.0011.97203,490.0017,000.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000040/0001723128-19-000040-index.htm
2019-03-12Robert A StewartPresident and CEOBuy17,000.0011.92202,640.0017,000.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000042/0001723128-19-000042-index.htm
2019-05-07Nikita ShahSVP, Chief HR OfficerBuy4,441.00170,477.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000087/0001723128-19-000087-index.htm
2019-05-08J KEVIN BUCHIDirectorBuy6,107.0017,408.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000074/0001723128-19-000074-index.htm
2020-03-01Nikita ShahSVP, Chief HR OfficerBuy11,728.00180,839.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320006809/0000899243-20-006809-index.htm
2020-05-07Nikita ShahSVP, Chief HR OfficerBuy4,442.00181,053.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320012453/0000899243-20-012453-index.htm
2019-05-08Janet S. VergisDirectorBuy6,107.0018,257.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000068/0001723128-19-000068-index.htm
2019-05-07ANDREW S BOYERExec VP, Comm OptnsBuy16,655.0018,655.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000090/0001723128-19-000090-index.htm
2019-05-07Joseph TodiscoSVP, Specialty CommercialBuy4,441.00192,818.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000091/0001723128-19-000091-index.htm
2020-03-03Chirag K. PatelPresident, Co-CEO & DirectorBuy156,421.003.88606,913.48197,169.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320007821/0000899243-20-007821-index.htm
2020-03-03Chintu PatelCo-CEO and DirectorBuy156,539.003.88607,371.32197,342.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320007819/0000899243-20-007819-index.htm
2020-01-22Todd P. BranningSVP and CFOBuy20,096.0020,096.00https://www.sec.gov/Archives/edgar/data/1723128/000120919120004719/0001209191-20-004719-index.htm
2019-05-13Joseph TodiscoSVP, Specialty CommercialBuy15,000.009.88148,200.00205,590.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000094/0001723128-19-000094-index.htm
2020-05-15Jeffrey P. GeorgeDirectorBuy23,810.004.1699,049.6023,810.00https://www.sec.gov/Archives/edgar/data/1723128/000120919120029727/0001209191-20-029727-index.htm
2020-05-07J KEVIN BUCHIDirectorBuy6,459.0023,867.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320012257/0000899243-20-012257-index.htm
2020-02-28Joseph TodiscoSVP, Specialty CommercialBuy40,000.003.62144,800.00246,845.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320006807/0000899243-20-006807-index.htm
2019-03-06PETER R TERRERIDirectorSell23,345.0012.39289,244.5525,192.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000038/0001723128-19-000038-index.htm
2020-03-04Chintu PatelCo-CEO and DirectorBuy58,765.003.97233,297.05256,107.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320007819/0000899243-20-007819-index.htm
2020-03-04Chirag K. PatelPresident, Co-CEO & DirectorBuy58,938.003.97233,983.86256,107.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320007821/0000899243-20-007821-index.htm
2020-05-07Joseph TodiscoSVP, Specialty CommercialBuy4,442.00256,236.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320012452/0000899243-20-012452-index.htm
2020-03-01Joseph TodiscoSVP, Specialty CommercialBuy11,111.00257,956.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320006807/0000899243-20-006807-index.htm
2020-08-02PAUL M MEISTERDirectorBuy27,923.0027,923.00https://www.sec.gov/Archives/edgar/data/1723128/000120919120044581/0001209191-20-044581-index.htm
2020-01-03DAVID A BUCHENSVP, Chief Legal OfficerBuy27,614.0028,614.00https://www.sec.gov/Archives/edgar/data/1723128/000172312820000002/0001723128-20-000002-index.htm
2019-05-13ANDREW S BOYERExec VP, Comm OptnsBuy19,000.009.46179,740.0029,302.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000095/0001723128-19-000095-index.htm
2019-08-06International Ltd Fosun10% Share HolderBuy327,000.002.91951,570.00327,000.00https://www.sec.gov/Archives/edgar/data/1723128/000114420419038365/0001144204-19-038365-index.htm
2020-03-18PAUL M MEISTERDirectorBuy204,210.002.71553,409.10353,649.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320009026/0000899243-20-009026-index.htm
2020-03-10Chintu PatelCo-CEO and DirectorBuy100,000.003.09309,000.00356,107.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320007990/0000899243-20-007990-index.htm
2020-03-10Chirag K. PatelPresident, Co-CEO & DirectorBuy100,000.003.09309,000.00356,107.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320007988/0000899243-20-007988-index.htm
2020-05-07Chintu PatelCo-CEO and DirectorBuy6,459.00362,566.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320012444/0000899243-20-012444-index.htm
2020-05-07Chirag K. PatelPresident, Co-CEO & DirectorBuy6,459.00362,566.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320012451/0000899243-20-012451-index.htm
2019-08-16Pradeep BhadauriaSVP, Chief Scientific OfficerBuy30,000.002.4172,300.0037,500.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000118/0001723128-19-000118-index.htm
2020-03-02Gautam PatelDirectorBuy32,111.003.88124,590.6838,218.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320007820/0000899243-20-007820-index.htm
2020-03-02Chirag K. PatelPresident, Co-CEO & DirectorBuy34,641.003.87134,060.6740,748.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320007821/0000899243-20-007821-index.htm
2020-03-02Chintu PatelCo-CEO and DirectorBuy34,696.003.87134,273.5240,803.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320007819/0000899243-20-007819-index.htm
2019-05-07PAUL BISAROExecutive ChairmanBuy24,983.0041,983.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000089/0001723128-19-000089-index.htm
2019-08-28Ted C NarkDirectorBuy50,000.002.39119,500.0056,107.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000120/0001723128-19-000120-index.htm
2019-05-08Chintu PatelDirectorBuy6,107.006,107.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000072/0001723128-19-000072-index.htm
2019-05-08Chirag K. PatelDirectorBuy6,107.006,107.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000065/0001723128-19-000065-index.htm
2019-05-08Dharmendra RamaDirectorBuy6,107.006,107.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000071/0001723128-19-000071-index.htm
2019-05-08Emily Peterson AlvaDirectorBuy6,107.006,107.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000064/0001723128-19-000064-index.htm
2019-05-08Gautam PatelDirectorBuy6,107.006,107.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000073/0001723128-19-000073-index.htm
2019-05-08Jean Selden GreeneDirectorBuy6,107.006,107.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000066/0001723128-19-000066-index.htm
2019-05-08Ted C NarkDirectorBuy6,107.006,107.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000070/0001723128-19-000070-index.htm
2020-05-07Ted C NarkDirectorBuy6,459.0062,566.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320012261/0000899243-20-012261-index.htm
2019-03-06PETER R TERRERIDirectorBuy45,000.006.55294,750.0070,192.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000038/0001723128-19-000038-index.htm
2019-05-15Pradeep BhadauriaSVP, Chief Scientific OfficerBuy7,000.008.4859,360.007,500.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000097/0001723128-19-000097-index.htm
2019-05-08PETER R TERRERIDirectorBuy6,107.0076,299.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000067/0001723128-19-000067-index.htm
2020-05-04PETER R TERRERIDirectorBuy6,459.0082,758.00https://www.sec.gov/Archives/edgar/data/1723128/000089924320012068/0000899243-20-012068-index.htm
2019-01-15ROBERT L BURRDirectorBuy30,000.006.55196,500.0090,475.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000013/0001723128-19-000013-index.htm
2019-08-07ANDREW S BOYERExec VP, Comm OptnsBuy66,666.002.89192,664.7495,968.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000116/0001723128-19-000116-index.htm
2019-05-08ROBERT L BURRDirectorBuy6,107.0096,582.00https://www.sec.gov/Archives/edgar/data/1723128/000172312819000069/0001723128-19-000069-index.htm